Table 1.
Substrates of SMOs and related proteins.
| Substrate | Enantioselectivity | Comment | Reference∗ |
|---|---|---|---|
| Chiral epoxidation reactions | |||
| Styrene | (S) | Model substrate | |
| Indene | (1S,2R) | Target for pharmaceutical industries as a precursor of indinavir | Hollmann et al., 2003; Lin et al., 2010 |
| Styrene with substitutions at the aromatic ring | (S) | Activity often similar to the model substrate styrene | |
| Styrene with substitutions at the vinyl chain | (S) | Mutations in the active site can change enantioselectivity in case of bulky substitutions | Lin et al., 2012; Toda et al., 2012a |
| Heterocyclic compounds | (S) | Formation of pyridine-like epoxides | Lin et al., 2010; Toda et al., 2012a |
| Non-conjugated alkenes including allylbenzenes | (S) | Much lower activity or rate of biotransformation compared to aromatic, conjugated substrates | Lin et al., 2010, 2011; Toda et al., 2012a,b, 2014 |
| Indole | n.d. | Product not determined yet, but it auto-catalytically forms indigo in presence of molecular oxygen | Toda et al., 2012b; Sadauskas et al., 2017 |
| Chiral sulfoxidation reactions | |||
| Aromatic sulfides (e.g., thioanisole) including derivatives with substitutions at the aromatic ring | (R), (S) | Thioanisole (methyl phenyl sulfide) is the model substrate Enantioselectivity depends on the type of enzyme selected | van Hellemond et al., 2007; Paul et al., 2015; Riedel et al., 2015 |
n.d., not determined. ∗References have been summarized by Montersino et al. (2011), Huijbers et al. (2014), and Tischler (2015). Furthermore, a number of important reference are given in the table to clarify comments or more recent findings.